Sponsor

BeBetter Med Inc

Clinical research sponsor

Published trials7

Recruiting shown5

Roles1

SourceClinicalTrials.gov

Clinical trials

7 shown

A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast CancerNCT07544056 · lead sponsor · 2026-06-04

RECRUITING

A Study of BEBT-701 in Patients With Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol（LDL-C）NCT07368608 · lead sponsor · 2026-03-01

RECRUITING

Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion MutationsNCT06514027 · lead sponsor · 2024-08-28

RECRUITING

Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine TherapyNCT06998108 · lead sponsor · 2022-06-09

RECRUITING

Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung CancerNCT06706713 · lead sponsor · 2022-04-15

RECRUITING

A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast CancerNCT06685796 · lead sponsor · 2023-04-12

COMPLETED

Phase I Study of BEBT-209 in Women With Advanced Breast CancerNCT06047184 · lead sponsor · 2019-07-15

COMPLETED

Sponsor roles

lead sponsor7

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.